<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00837018</url>
  </required_header>
  <id_info>
    <org_study_id>0520</org_study_id>
    <secondary_id>DGS 2005/0312</secondary_id>
    <nct_id>NCT00837018</nct_id>
  </id_info>
  <brief_title>Exercise Intolerance in Obstructive Sleep Apnea Syndrome Patients</brief_title>
  <acronym>EXAOS</acronym>
  <official_title>Exercise Intolerance in Obstructive Sleep Apnea Syndrome Patients: Cardiovascular and Metabolic Characterisation During Exercise. Treatments Effect.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AGIR Ã  Dom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The syndrome of obstructive sleep apnea (OSAS) is a public health problem that affects 2 to&#xD;
      4% of the general population. The patients with OSAS frequently complain of intolerance to&#xD;
      exercise muscle fatigue and a significant even if they have not been fully characterized in&#xD;
      the literature.&#xD;
&#xD;
      The anomalies in the exercise of patients with OSAS could be due to metabolic changes&#xD;
      (insulin resistance and oxidative stress) and cardiovascular (impaired vascular reactivity).&#xD;
&#xD;
      Our goal is both to determine whether these anomalies exist in patients with OSAS not obese,&#xD;
      consider their relationship with the alteration of exercise capacity, and their reversibility&#xD;
      in conventional PPC or by using the effects of physical activity regular.In this study&#xD;
      Objectives: To establish whether the metabolic and vascular abnormalities associated with&#xD;
      OSAS are associated with decreased parameters of physical fitness in relation to witnesses&#xD;
      matched for age, sex and body mass index. Determine the effects of a re-training exercise on&#xD;
      these parameters compared to the reference treatment, continuous positive pressure.&#xD;
&#xD;
      Main objective: To compare the exercise capacity of OSAS patients compared with that of&#xD;
      witnesses matched for age, sex and body mass index.&#xD;
&#xD;
      Secondary objectives: To compare the effect of conventional treatment by continuous positive&#xD;
      pressure (CPP) on cardiovascular and metabolic abnormalities of OSAS, with a therapeutic&#xD;
      modality most original, physical activity.&#xD;
&#xD;
      Methodology: Test physiopathological parallel group, controlled, randomized.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study type : Physiopathology trial Study design : Prospective randomized controled trial&#xD;
&#xD;
      Expected Total Enrollment : 45 patients + 15 control subjects&#xD;
&#xD;
      Tested treatment : Physical exercise program (45 minutes, 3 times a week) Reference treatment&#xD;
      : continuous positive airway pressure Treatment duration : 12 weeks (3 months) Total study&#xD;
      duration : 2 years&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of maximal oxygen consumption : OSAS patient versus control subjects.</measure>
    <time_frame>when the last patient realised the last visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare physical exercise program to continuous positive airway pressure after 12 weeks of treatment in OSAS patients.</measure>
    <time_frame>when the last patient realised the last visit</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Physical exercise program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>45 min, 3 times a week</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>physical exercise program</intervention_name>
    <description>45 min, 3times a week</description>
    <arm_group_label>Physical exercise program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ages Eligible for Study : 18 Years and above&#xD;
&#xD;
          -  Genders Eligible for Study: Both&#xD;
&#xD;
          -  Non obese : body mass index (BMI &lt; 30 kg/m2)&#xD;
&#xD;
          -  Sedentary subjects : less physical activity than 30 minutes 3 time a week&#xD;
&#xD;
          -  and VOORIPS physical activity level questionnaire score &lt; 9.&#xD;
&#xD;
        Obstructive sleep apnea syndrome (OSAS) patients :&#xD;
&#xD;
          -  Recently diagnosed (&lt; 3 months)&#xD;
&#xD;
          -  AHI &gt; 30 / hour (polysomnographic monitoring measurement)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Excessive daytime sleepiness (Epworth score &gt; 12)&#xD;
&#xD;
          -  Cardiovascular pathology (except controlled hypertension)&#xD;
&#xD;
          -  Pathology interacting with physical activity&#xD;
&#xD;
          -  Diabetes (known or treated)&#xD;
&#xD;
          -  Other participation to a clinical trial at the same&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Wuyam, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU, medecine du sport</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <study_first_submitted>February 3, 2009</study_first_submitted>
  <study_first_submitted_qc>February 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2009</study_first_posted>
  <last_update_submitted>March 4, 2013</last_update_submitted>
  <last_update_submitted_qc>March 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OSAS</keyword>
  <keyword>exercise</keyword>
  <keyword>metabolic</keyword>
  <keyword>cardio-vascular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

